Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 19 years or older
- People who have been assessed as suitable candidates for treatment with a drug-coated or drug-eluting stent (a small mesh tube placed in an artery) due to a condition called acute coronary syndrome (a sudden, serious heart condition such as a heart attack or unstable chest pain)
- People who have given their written agreement to take part in the trial
Who may not be able to join:
- People who are currently pregnant or who may become pregnant during the trial
- People who need to take blood-thinning tablets (oral anticoagulants) as part of their regular treatment
- People whom the trial investigator does not expect to be able to follow up with over the full 1-year period after joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chul-Min Ahn, Yonsei University Health System, Severance Hospital
Phone: +82-2-2228-8532
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient-Oriented Composite Endpoint (POCE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.